Bumetanide - NDC Database (Page 7)
70860-406 Feb 08, 2022
Bumetanide .25 mg/ml Intramuscular; Intravenous Injection, Solution by Athenex Pharmaceutical Division, LLC.
Bumetanide .25 mg/ml Intramuscular; Intravenous Injection, Solution by Athenex Pharmaceutical Division, LLC.
72205-101 Aug 06, 2022
Bumetanide .25 mg/ml Intramuscular; Intravenous Injection by Novadoz Pharmaceuticals LLC
Bumetanide .25 mg/ml Intramuscular; Intravenous Injection by Novadoz Pharmaceuticals LLC
72205-102 Aug 06, 2022
Bumetanide .25 mg/ml Intramuscular; Intravenous Injection by Novadoz Pharmaceuticals LLC
Bumetanide .25 mg/ml Intramuscular; Intravenous Injection by Novadoz Pharmaceuticals LLC
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.